4.7800
+0.0400
+(0.84%)
At close: January 30 at 4:00:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-37,415.0000
-39,527.0000
-28,424.0000
-28,913.0000
-15,212.0000
Investing Cash Flow
-12,856.0000
-45,287.0000
--
--
11,035.0000
Financing Cash Flow
53,355.0000
33,017.0000
--
-449.0000
109,581.0000
End Cash Position
6,751.0000
4,612.0000
56,409.0000
84,833.0000
114,195.0000
Issuance of Capital Stock
53,355.0000
33,017.0000
--
--
104,226.0000
Free Cash Flow
-37,415.0000
-39,527.0000
-28,424.0000
-28,913.0000
-15,212.0000
12/31/2020 - 9/17/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PYPD PolyPid Ltd.
2.9899
+0.33%
ABOS Acumen Pharmaceuticals, Inc.
1.5600
-0.64%
LRMR Larimar Therapeutics, Inc.
3.9700
+7.01%
PEPG PepGen Inc.
1.4400
-21.74%
RZLT Rezolute, Inc.
5.21
+2.96%
TSBX Turnstone Biologics Corp.
0.4840
-0.21%
TARA Protara Therapeutics, Inc.
4.5000
-0.44%
ORIC ORIC Pharmaceuticals, Inc.
10.77
-3.41%
BRNS Barinthus Biotherapeutics plc
1.0000
+5.26%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%